Total medical devices industry deals for September 2019 worth $2.15bn were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 18.5% over the previous month and a drop of 56% when compared with the last 12-month average of $4.89bn.
In terms of number of deals, the sector saw a rise of 4.1% over the last 12-month average with 127 deals against the average of 122 deals.
In value terms, North America led the activity with deals worth $1.11bn.
Medical devices industry deals in September 2019: Top deals
The top five medical devices deals accounted for 68.9% of the overall value during September 2019.
The combined value of the top five medical devices deals stood at $1.48bn, against the overall value of $2.15bn recorded for the month.
The top five medical devices industry deals of September 2019 tracked by GlobalData were:
1) Stryker’s $500m acquisition of GYS Tech and Mobius Imaging
2) The $450m acquisition of EndoSpan by CryoLife
3) Cambridge Innovation Capital, Escala Capital Investments Cyprus, LGT Impact Ventures, Silk Road Fund and Watrium’s $242.67m venture financing of CMR Surgical
4) The $230m acquisition of Cheetah Medical by Baxter International
5) Aleph Venture Capital, Ansonia Holdings Singapore, Joy Capital and Samsung NEXT Ventures’ venture financing of Healthy io for $60m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.